BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10877055)

  • 1. Pentostatin (Nipent) in T-cell lymphomas.
    Kurzrock R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):64-6. PubMed ID: 10877055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
    Foss FM
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):58-63. PubMed ID: 10877054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of T cell lymphomas with pentostatin.
    Kurzrock R
    Ann N Y Acad Sci; 2001 Sep; 941():200-5. PubMed ID: 11594574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions for pentostatin (Nipent) usage in dermatology.
    Heald P
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):3-8. PubMed ID: 10877044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series.
    Tsimberidou AM; Giles F; Duvic M; Fayad L; Kurzrock R
    Cancer; 2004 Jan; 100(2):342-9. PubMed ID: 14716770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE; Matutes E; Catovsky D
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentostatin therapy of T-cell lymphomas with cutaneous manifestations.
    Kurzrock R; Pilat S; Duvic M
    J Clin Oncol; 1999 Oct; 17(10):3117-21. PubMed ID: 10506607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia.
    Weiss MA
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):41-3. PubMed ID: 10877051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentostatin (Nipent): a review of potential toxicity and its management.
    Margolis J; Grever MR
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):9-14. PubMed ID: 10877045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
    Dang NH; Hagemeister FB; Duvic M; Romaguera JE; Younes A; Jones D; Samuels B; Fayad LE; Pro B; Samaniego F; Sarris A; Goy A; McLaughlin P; Tong AT; Walker PL; Tiongson LP; Smith TL; Huh YO; Morimoto C; Rodriguez MA
    Oncol Rep; 2003; 10(5):1513-8. PubMed ID: 12883733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentostatin treatment of cutaneous T-cell lymphoma.
    Dearden C; Matutes E; Catovsky D
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):37-40. PubMed ID: 10887643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group.
    Tobinai K; Shimoyama M; Inoue S; Takayasu S; Mikuni C; Kozuru M; Oda S; Nakajima H
    Jpn J Clin Oncol; 1992 Jun; 22(3):164-71. PubMed ID: 1518164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible pentostatin-induced symptomatic hyponatremia.
    Bruno JJ; Canada TW
    Pharmacotherapy; 2007 Jan; 27(1):164-9. PubMed ID: 17192171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pentostatin treatment for a patient with chronic type adult T-cell leukemia undergoing hemodialysis].
    Arima N; Sugiyama T
    Rinsho Ketsueki; 2005 Nov; 46(11):1191-5. PubMed ID: 16440802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Ann Oncol; 1999 Dec; 10(12):1493-8. PubMed ID: 10643542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentostatin (2'-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma.
    Greiner D; Olsen EA; Petroni G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):950-5. PubMed ID: 9204061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.